Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary transplantations. Current assessment]

R Pariente

    Presse Medicale (Paris, France : 1983)
    |July 5, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Lung transplantation survival rates reach 60% at 3 years and 41% at 7 years. Despite advancements, donor shortages and chronic rejection remain significant challenges for end-stage respiratory failure treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Flow cytometric analysis of duodenal intraepithelial lymphocytes (celiac lymphogram): A diagnostic test for celiac disease.

    Methods in cell biology·2023
    Same author

    Severe tracheobronchial stenosis in a patient with Crohn's disease.

    The European respiratory journal·2000
    Same author

    [Role of surgery in the treatment of obstructive respiratory insufficiency].

    Bulletin de l'Academie nationale de medecine·1998
    Same author

    Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation.

    The American journal of physiology·1998
    Same author

    Early release of proinflammatory cytokines after lung transplantation.

    Chest·1998
    Same author

    [Selection criteria of candidates for lung transplantation].

    Revue des maladies respiratoires·1998
    Same journal

    Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Ethical, legal, and regulatory challenges in AI-based healthcare tools.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Decision-making for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pulmonology
    • Transplant Surgery

    Background:

    • Lung transplantation is a critical treatment for end-stage respiratory failure.
    • Survival rates have improved significantly over fifteen years of experience.

    Discussion:

    • Early post-transplant complications like edema and shock are manageable.
    • Acute rejection episodes, often linked to viral infections (herpes, cytomegalovirus), occur within three months and may resist antiviral treatment.
    • Chronic rejection, occurring after nine months and sometimes extending beyond three years, is a major cause of long-term graft failure, accounting for 25% of cases.

    Key Insights:

    • Survival rates after lung transplantation have significantly improved over fifteen years.
    • While early complications are generally controlled, acute and chronic rejection remain critical issues impacting long-term outcomes.

    Related Experiment Videos

  • The primary obstacle to wider application of lung transplantation is the critical shortage of suitable donors, leading to extensive waiting lists.

    • Outlook:

    • Further research into managing and preventing chronic rejection is crucial.
    • Strategies to increase donor availability are urgently needed to address the disparity between demand and supply.
    • Advancements in immunosuppressive therapies may offer better control over rejection episodes, improving long-term graft survival.